The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis.
about
Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentiumLinking the microbiota and metabolic disease with lymphotoxinDevelopment and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the ColonLymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection.GM-CSF-facilitated dendritic cell recruitment and survival govern the intestinal mucosal response to a mouse enteric bacterial pathogen.Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway.CD4+-T-cell effector functions and costimulatory requirements essential for surviving mucosal infection with Citrobacter rodentium.Lymphotoxin, NF-ĸB, and cancer: the dark side of cytokines.Citrobacter rodentium of mice and man.Vitamin A supplementation modifies the association between mucosal innate and adaptive immune responses and resolution of enteric pathogen infections.Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasisStimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection.Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota.Development of fatal colitis in FVB mice infected with Citrobacter rodentiumLymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.A discrete ubiquitin-mediated network regulates the strength of NOD2 signaling.Animal models of inflammatory bowel disease: lessons from enteric infections.Role of lymphotoxins in the development of Peyer's patches and mesenteric lymph nodes: relevance to intestinal inflammation and treatment.Recent understanding of IBD pathogenesis: implications for future therapies.The absence of cutaneous lymph nodes results in a Th2 response and increased susceptibility to Leishmania major infection in miceIL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogensRegulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partnersLymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cellsIL-22, not simply a Th17 cytokine.Lymphotoxin signalling in immune homeostasis and the control of microorganisms.Cytokines IL-17 and IL-22 in the host response to infection.Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance.Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.Hematopoietic LTβR deficiency results in skewed T cell cytokine profiles during a mucosal viral infection.Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo.IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium.CD4+ T cells transfer resistance against Citrobacter rodentium-induced infectious colitis by induction of Th 1 immunity.
P2860
Q24655784-9F40B5A1-617F-4C81-84C4-477BAE8BCCFEQ26996602-FAD036D9-311A-4007-ACA0-A6B1519DF49FQ28071695-6F5920A1-FEC0-4E2B-A124-81E0F88033F6Q33883606-C34C4156-F414-4A74-A721-C0581B03FAF0Q34058590-896D7EE6-2A9C-431A-88A1-2C1B468E8AE5Q34111943-56DC9F22-B061-4C20-B52A-39D8AA6B34BBQ34300967-C30B0DE6-7673-4687-80CF-130B9572128EQ34308847-AD9153C1-01D7-40F7-BAFF-1FA3B835F37AQ34470352-6A91AD7E-3120-46E8-8D10-0A8A5F918DC7Q34585296-86BC0378-E75D-4874-92B0-07B834855F64Q34969719-F33859F5-07E5-4A82-A730-3794B46F8C52Q35080739-02C37242-B519-4D43-8EFC-536457BAE20AQ35608607-FB85CC81-5A8F-45AB-AD9A-70BDFE181042Q35611711-0753EE4A-7F91-4E01-9EDE-3F21F56706B4Q35913654-345CD820-4685-4C8B-829E-29A6B1CE0BF9Q36031510-97E86CA5-B41F-4CAC-AAF8-7148DE73FAD1Q36506610-68AEB868-DF32-4CC9-B906-7F94B457FF7FQ36631411-3B999A84-4F54-4156-8840-B1D89B61E948Q36631451-2719AFC2-4BC2-4140-BFEA-8687EDDED4F4Q36639759-D4A07750-CAA3-4AC9-AD82-8531C9055DBFQ36845128-80F04EEF-8330-43E3-BE9C-608B63E87AC0Q37226694-C6944BDF-D004-4D26-BF8E-611B825A5895Q37398839-0AC6CACD-A3CD-4B15-A31E-38577B119312Q37722321-61E70F95-0064-434A-9F8F-8F1A39DD4ADEQ38081171-0EB416D7-FE2C-4F59-91D7-3AA4F309A944Q38092570-5096E421-48F7-4D6F-B7B7-4F830F9C91C2Q39028574-B7D2264F-C670-4EA6-A097-4127D11827F9Q39203747-3E59A16E-A388-4FB2-A563-F53499E1A6A3Q40185624-81DD00F5-91D0-4C59-BA55-36981A2A874DQ40874904-438CB87E-F824-4836-B89B-6388981DFD3FQ41445006-B98DCA93-E508-45B0-B21F-17DBBB968EA1Q46485022-09711BA5-5589-4728-9BE0-7B193D50F367Q54426772-D66F1BC8-75D5-4E30-BE4D-0E998B74DE32
P2860
The lymphotoxin-beta receptor is critical for control of murine Citrobacter rodentium-induced colitis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@en
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@nl
type
label
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@en
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@nl
prefLabel
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@en
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@nl
P2093
P1433
P1476
The lymphotoxin-beta receptor ...... ter rodentium-induced colitis.
@en
P2093
Andreas Lügering
Christian Maaser
Hermann Herbst
Jan Heidemann
Lars Eckmann
Thomas W Spahn
Torsten Kucharzik
P304
P356
10.1053/J.GASTRO.2004.08.022
P407
P577
2004-11-01T00:00:00Z